Hyperforin dicyclohexylammonium salt

[ Molecular Formula ]:
C₄₇H₇₅NO₄

[ Molecular Weight ]:
718.10300

[ Exact Mass ]:
717.57000

[ PSA ]:
83.47000

[ LogP ]:
12.62200

[ Symbol ]:

GHS05, GHS07, GHS09

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H302-H314-H400

[ Precautionary Statements ]:
P273-P280-P305 + P351 + P338-P310

[ RIDADR ]:
UN 1759 8 / PGIII

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.

Mol. Cancer Ther. 10 , 336-46, (2011)

Oncogenic KRAS is found in more than 25% of lung adenocarcinomas, the major histologic subtype of non-small cell lung cancer (NSCLC), and is an important target for drug development. To this end, we g...

Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.

Clin. Cancer Res. 15 , 6852-61, (2009)

Signal transducer and activator of transcription-3 (STAT3) is downstream of growth factor and cytokine receptors, and regulates key oncogenic pathways in non-small cell lung cancer (NSCLC). Activation...

Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.

Cancer Res. 70 , 9185-96, (2010)

Increasing evidence points to the functional importance of alternative splice variations in cancer pathophysiology. Two splice variants are derived from the CASP9 gene via the inclusion (Casp9a) or ex...

More Articles